Enhanced binding of tissue factor-microparticles to collagen-IV and fibronectin leads to increased tissue factor activity in vitro

Thrombosis and Haemostasis

Volumn 109, Issue 1, 2013, Pages 61-71

  Ettelaie, Camille ^a   Collier, Mary E W ^a   Mei, Mah Pui ^a   Xiao, Yu Pei ^a   Maraveyas, Anthony ^b  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Endothelial derived microparticles; Extracellular matrices; Integrins; Procoagulant activity; Tissue factor

Indexed keywords

BETA1 INTEGRIN; BETA3 INTEGRIN; CD18 ANTIGEN; COLLAGEN TYPE 4; FIBRIN; FIBRONECTIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL DENSITY; CELL INTERACTION; CELL SIZE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SHEAR RATE; WESTERN BLOTTING;

ANTIBODIES, BLOCKING; ANTIGENS, CD29; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; FIBRIN; FIBRONECTINS; HUMANS; INTEGRIN ALPHA3; INTEGRIN ALPHAV; INTEGRIN BETA3; PROTEIN BINDING; THROMBOPLASTIN; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84872229179     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-05-0279     Document Type: Article

References (35)

1. Chironi GN, Boulanger CM, Simon A, et al. Endothelial microparticles in diseases. Cell Tissue Res 2008; 335: 143-151.
2. Rautou PE, Vion AC, Amabile N, et al. Microparticles, vascular function, and atherothrombosis. Circ Res 2011; 109: 593-606.
3. Morel O, Hugel B, Jesel L, et al. Procoagulant membranous microparticles and atherothrombotic complications in diabetics. Arch Mal Coeur Vaiss 2004; 97: 1006-1012.
4. VanWijk MJ, VanBavel E, Struk A, et al. Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277-287.
5. Martínez MC, Tesse A, Zobairi F, et al. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005; 288: H1004-1009.
6. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial microparticles (EMP) as vascular disease markers. Adv Clin Chem 2005; 39: 131-157.
7. Gross PL, Furie BC, Merrill-Skoloff G, et al. Leukocyte-versus microparticlemediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol 2005; 78: 1318-1326.
8. Biró E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2005; 1: 2561-2568.
9. Abid Hussein MN, Böing AN, Biró E, et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res 2008; 121: 865-871.
10. Horstman LL, Jy W, Jimenez JJ, et al. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-1135.
11. Mallat Z, Hugel B, Ohan J, et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353.
12. Leroyer AS, Isobe H, Lesèche G, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J. Am. Coll. Cardiol 2007; 49: 772-777.
13. Biró E, Sturk-Maquelin KN, Vogel GM, et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 2008; 6: 913-919.
14. Falati S, Gross P, Merrill-Skoloff G, et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8: 1175-1181.
15. Chou J, Mackman N, Merrill-Skoloff G, et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190-3197.
16. Diamond SL. Tissue factor activity under flow. Thromb. Res 2010; 125 (Suppl 1): S29-30.
17. Zwicker JI, Trenor CC 3rd, Furie BC, et al. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol 2011; 31: 728-733.
18. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
19. Ramacciotti E, Hawley AE, Farris DM, et al. Leukocyte-and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 2009; 101: 748-754.
20. Furie B, Furie BC. In vivo thrombus formation. J Thromb Haemost 2007; 5 (Suppl 1): 12-17.
21. Colace TV, Jobson J, Diamond SL. Relipidated tissue factor linked to collagen surfaces potentiates platelet adhesion and fibrin formation in a microfluidic model of vessel injury. Bioconjug Chem 2011; 22: 2104-2109.
22. Keuren JF, Magdeleyns EJ, Bennaghmouch A, et al. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol 2007; 138: 527-533.
23. Merten M, Pakala R, Thiagarajan P, et al. Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99: 2577-2582.
24. Collier ME, Ettelaie C. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor. J Biol Chem 2011; 286: 11977-11984.
25. Collier ME, Ettelaie C. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation. Arterioscler Thromb Vasc Biol 2010; 30: 1810-1817.
26. Ettelaie C, Fountain D, Collier MEW, et al. Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-αB. Biochim Biophys Acta Mol Basis Dis 2011; 1812: 591-600.
27. Ettelaie C, Su S, Li C, et al. Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells. Microvasc Res 2008; 76: 152-160.
28. Bonnekoh B, Wevers A, Jugert F, et al. Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res 1989; 281: 487-490.
29. Collier ME, Li C, Ettelaie C. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation. Mol Cancer Res 2008; 6: 1807-1818.
30. Kuharsky AL, Fogelson AL. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys J 2001; 80: 1050-1074.
31. Pluskota E, Woody NM, Szpak D, et al. Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. Blood 2008; 112: 2327-2335.
32. Versteeg HH, Schaffner F, Kerver M, et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood. 2008; 111: 190-199.
33. Schecter AD, Spirn B, Rossikhina M, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000; 87: 126-132.
34. Furlan-Freguia C, Marchese P, Gruber A, et al. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011; 121: 2932-2944.
35. Patchipulusu S, Turturro M, Hall CL. Monocyte-derived macrophage microparticles impart tissue factor activity to biomaterial surfaces. J Biomed Mater Res A 2010; 92: 724-732.